Pfizer has not sold to any country without obtaining indemnity against legal action over any adverse effects of their product. India has no...

The govt could essentially function as a canalising agency to facilitate supply of these vaccines in the country. Pfizer had not participat...

The final agreement between the government and the American drug-maker on indemnity and procurement norms are still pending, though the two...

“For India, Pfizer has offered a not-for-profit price for its vaccine for the government immunization programme. We continue to be in discu...

The new regulatory requirement is that the first 100 patients to receive the jab will be observed for seven days for any serious adverse re...

The U.S. company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its...

Israel is giving weekly data updates on its Covid-19 outbreak to vaccine maker Pfizer under a collaboration agreement that may help other c...

The company also said governments globally are developing comprehensive and strategic pandemic response plans. At this time, it is most app...

“We will have tiered pricing for middle-income countries (India is considered a middle-income country) and we will give it for free in Afri...

The firm, in its application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in the ...

"Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of U...

Global drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the final analysis o...

The company is in discussions with the Gavi vaccine alliance to potentially provide doses to the Covax facility, a Pfizer spokesperson told...

The Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the bran...

India has seven pneumonia related deaths per 1,000 live births, according to the 2016 Pneumonia and Diarrhea Progress Report.

MSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious a...

Not-for-profit medical charity Doctors Without Borders (MSF) has challenged a patent application of US drug major Pfizer in India for its p...